NSE - Delayed Quote INR

Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS.NS)

Compare
61.28 -2.13 (-3.36%)
At close: October 22 at 3:27 PM GMT+5:30
Currency in INR All numbers in thousands
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Total Revenue
4,715,734.93
3,956,178.93
4,189,561.26
4,916,097.00
3,478,884.87
--
Cost of Revenue
4,574,863.11
3,818,986.11
4,038,406.37
4,720,549.00
3,377,902.38
--
Gross Profit
140,871.83
137,192.83
151,154.90
195,548.00
100,982.50
--
Operating Expense
115,439.98
109,659.98
89,681.88
100,673.00
63,799.08
--
Operating Income
25,431.84
27,532.84
61,473.02
94,875.00
37,183.42
--
Net Non Operating Interest Income Expense
-44,374.64
-43,752.64
-28,670.93
-311.00
-28.30
--
Pretax Income
59,490.19
53,429.19
60,096.35
100,371.00
83,013.80
--
Tax Provision
7,510.52
6,592.52
22,385.52
34,823.00
17,870.74
--
Net Income Common Stockholders
51,980.67
46,836.67
37,710.83
65,548.00
65,143.06
--
Diluted NI Available to Com Stockholders
51,980.67
46,836.67
37,710.83
65,548.00
65,143.06
--
Basic EPS
1.99
1.84
1.49
2.72
2.79
--
Diluted EPS
1.99
1.84
1.49
2.72
2.79
--
Basic Average Shares
28,721.71
28,054.30
25,384.68
24,075.00
23,384.68
--
Diluted Average Shares
28,721.71
28,054.30
25,384.68
24,075.00
23,384.68
--
Rent Expense Supplemental
--
--
4,879.00
6,823.00
6,697.72
5,322.72
Total Expenses
4,690,303.09
3,928,646.09
4,128,088.24
4,821,222.00
3,441,701.45
--
Net Income from Continuing & Discontinued Operation
51,980.67
46,836.67
37,710.83
65,548.00
65,143.06
--
Normalized Income
51,980.67
46,836.67
37,710.83
65,830.77
65,143.06
--
Interest Income
--
--
26,331.00
20,086.00
24,287.61
26,640.49
Interest Expense
44,374.64
43,752.64
28,670.93
19,123.00
23,182.03
--
Net Interest Income
-44,374.64
-43,752.64
-28,670.93
-311.00
-28.30
--
EBIT
103,864.83
97,181.83
88,767.28
119,494.00
106,195.82
--
EBITDA
121,341.83
114,161.83
104,505.28
139,377.00
115,400.04
--
Reconciled Cost of Revenue
4,574,863.11
3,818,986.11
4,038,406.37
4,720,549.00
3,377,902.38
--
Reconciled Depreciation
17,477.00
16,980.00
15,738.00
19,883.00
9,204.22
--
Net Income from Continuing Operation Net Minority Interest
51,980.67
46,836.67
37,710.83
65,548.00
65,143.06
--
Total Unusual Items Excluding Goodwill
--
--
--
-433.00
--
--
Total Unusual Items
--
--
--
-433.00
--
--
Normalized EBITDA
121,341.83
114,161.83
104,505.28
139,810.00
115,400.04
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
--
--
--
-150.23
--
--
3/31/2020 - 8/6/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers